Literature DB >> 4395744

The action of pharmacologically active substances on the flow and composition of cat hind limb lymph.

G P Lewis, N J Winsey.   

Abstract

1. Lymph flow, blood flow and lymph protein concentrations have been measured in cat hind limb.2. When naturally occurring pharmacologically active compounds were infused close arterially to the hind limb it was found that histamine, bradykinin and acetylcholine were the most potent in increasing lymph flow.3. Dilatation of blood vessels per se is not sufficient to cause an increase in lymph flow since potent vasodilator agents such as isoprenaline and prostaglandins were not very active in increasing lymph flow.4. The effect on blood flow was rapid in onset and in return to basal flow, whereas the effect on lymph flow was delayed and prolonged. The duration of the effect on lymph flow was considerably greater with histamine and bradykinin than with acetylcholine.5. An increase in the protein concentration in the interstitial fluid is not a pre-requisite of an increase in lymph flow because (a) in some experiments an increase in lymph flow was not accompanied by an increase in lymph protein concentration after infusion of vasoactive substance and (b) the glucofuranoside, Glyvenol, was found to inhibit the increase in protein concentration but not the increase in lymph flow caused by infusion of histamine or bradykinin.6. In contrast the specific antihistamine, mepyramine, abolished the effect of histamine on lymph flow and lymph protein concentration and considerably reduced the effect on blood flow.7. An increase in venous pressure alone caused a small increase of lymph flow in about 50% of experiments, but when the venous pressure was increased at a time when vascular permeability was high, there was an increase in lymph flow in all experiments.8. When the venous pressure was low only histamine caused a significant increase in the lymph protein concentration, whereas bradykinin sometimes caused a small increase and acetylcholine mostly caused a decrease in the concentration of lymph protein.9. When the venous pressure was high, bradykinin and histamine and occasionally acetylcholine caused an increase in protein concentration in the lymph.10. Infusions of histamine, bradykinin or prostaglandin E(1) did not increase the leakage of intracellular enzymes into the lymph.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4395744      PMCID: PMC1703187     

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  7 in total

1.  KININ-FORMING ACTIVITY AND HISTAMINE IN LYMPH AFTER TISSUE INJURY.

Authors:  H EDERY; G P LEWIS
Journal:  J Physiol       Date:  1963-12       Impact factor: 5.182

2.  Relationship between lymphatic and venous pressure in leg of dog.

Authors:  A IRISAWA; R F RUSHMER
Journal:  Am J Physiol       Date:  1959-03

3.  [A chemically and pharmacologically novel antagonist of physiopathologically important amines, kinins and kinin-forming factors].

Authors:  R Jaques; G Huber; L Neipp; A Rossi; B Schär; R Meier
Journal:  Experientia       Date:  1967-02-15

4.  Short communication: some actions of a benzyl-glucofuranoside on isolated veins.

Authors:  H Helfer; R Jaques
Journal:  Helv Physiol Pharmacol Acta       Date:  1967

5.  Intracellular enzymes in local lymph after chemical injury.

Authors:  S Boyles; G P Lewis; B Westcott
Journal:  Br J Pharmacol       Date:  1970-02       Impact factor: 8.739

6.  Intracellular enzymes in local lymph as a measure of cellular injury.

Authors:  G P Lewis
Journal:  J Physiol       Date:  1967-08       Impact factor: 5.182

7.  Changes in the composition of rabbit hind limb lymph after thermal injury.

Authors:  G P Lewis
Journal:  J Physiol       Date:  1969-12       Impact factor: 5.182

  7 in total
  10 in total

1.  The effect of electrical stimulation of the sympathetic chain on peripheral lymph flow in the anaesthetized sheep.

Authors:  J G McGeown; N G McHale; K D Thornbury
Journal:  J Physiol       Date:  1987-12       Impact factor: 5.182

2.  The effect of intravenous adrenaline and noradrenaline infusion of peripheral lymph flow in the sheep.

Authors:  N G McHale; I C Roddie
Journal:  J Physiol       Date:  1983-08       Impact factor: 5.182

3.  Substance P activates both contractile and inflammatory pathways in lymphatics through the neurokinin receptors NK1R and NK3R.

Authors:  Sanjukta Chakraborty; Zhanna Nepiyushchikh; Michael J Davis; David C Zawieja; Mariappan Muthuchamy
Journal:  Microcirculation       Date:  2011-01       Impact factor: 2.628

Review 4.  Convective diffusion of nanoparticles from the epithelial barrier toward regional lymph nodes.

Authors:  Stanislav S Dukhin; Mohamed E Labib
Journal:  Adv Colloid Interface Sci       Date:  2013-06-10       Impact factor: 12.984

Review 5.  Lymphatic system: a vital link between metabolic syndrome and inflammation.

Authors:  Sanjukta Chakraborty; Scott Zawieja; Wei Wang; David C Zawieja; Mariappan Muthuchamy
Journal:  Ann N Y Acad Sci       Date:  2010-10       Impact factor: 5.691

6.  Effects of histamine on the contractile and electrical activity in isolated lymphatic vessels of the guinea-pig mesentery.

Authors:  James L R Fox; Pierre-Yves von der Weid
Journal:  Br J Pharmacol       Date:  2002-08       Impact factor: 8.739

7.  The effects of isoprenaline and bradykinin on capillary filtration in the cat small intestine.

Authors:  D N Granger; P D Richardson; A E Taylor
Journal:  Br J Pharmacol       Date:  1979-11       Impact factor: 8.739

8.  Histamine weal formation and absorption in man.

Authors:  J Cook; S Shuster
Journal:  Br J Pharmacol       Date:  1980-08       Impact factor: 8.739

9.  Decreases in histamine forming enzyme activity of non-metastasizing fibrosarcomas in hamsters with progressive tumor growth.

Authors:  T C Moore; L E Koppelman; C A Lemmi
Journal:  Ann Surg       Date:  1978-08       Impact factor: 12.969

10.  The effects of histamine on skeletal muscle vasculature in cats.

Authors:  S B Flynn; D A Owen
Journal:  J Physiol       Date:  1977-03       Impact factor: 5.182

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.